2MH4
 
 | |
2N7S
 | | Solution Structure of Leptospiral LigA4 Big Domain | | Descriptor: | Ig-like repeat domain protein 1 | | Authors: | Mei, S. | | Deposit date: | 2015-09-17 | | Release date: | 2015-10-21 | | Last modified: | 2024-05-15 | | Method: | SOLUTION NMR | | Cite: | Solution structure of leptospiral LigA4 Big domain.
Biochem. Biophys. Res. Commun., 467, 2015
|
|
2NB4
 | | Solution structure of Q388A3 PDZ domain | | Descriptor: | Putative uncharacterized protein | | Authors: | Mei, S. | | Deposit date: | 2016-01-24 | | Release date: | 2016-02-24 | | Last modified: | 2024-05-15 | | Method: | SOLUTION NMR | | Cite: | Solution structure of Q388A3 PDZ domain from Trypanosoma brucei
J.Struct.Biol., 194, 2016
|
|
2N7P
 | | Solution structure of PDZ domain | | Descriptor: | Putative uncharacterized protein | | Authors: | Mei, S. | | Deposit date: | 2015-09-17 | | Release date: | 2015-10-07 | | Last modified: | 2024-05-15 | | Method: | SOLUTION NMR | | Cite: | Solution structure of Q388A3 PDZ domain from Trypanosoma brucei and its interaction with OMP-like peptide
To be Published
|
|
2MQG
 | |
8OQJ
 | |
8OSY
 | |
1SP7
 | | Structure of the Cys-rich C-terminal domain of Hydra minicollagen | | Descriptor: | mini-collagen | | Authors: | Meier, S, Haussinger, D, Pokidysheva, E, Bachinger, H.P, Grzesiek, S. | | Deposit date: | 2004-03-16 | | Release date: | 2004-05-18 | | Last modified: | 2022-03-02 | | Method: | SOLUTION NMR | | Cite: | Determination of a high-precision NMR structure of the minicollagen cysteine rich domain from Hydra and characterization of its disulfide bond formation.
Febs Lett., 569, 2004
|
|
2HM3
 | | Nematocyst outer wall antigen, cysteine rich domain NW1 | | Descriptor: | Nematocyst outer wall antigen | | Authors: | Meier, S, Jensen, P.R, Grzesiek, S, Oezbek, S. | | Deposit date: | 2006-07-11 | | Release date: | 2007-02-06 | | Last modified: | 2022-03-09 | | Method: | SOLUTION NMR | | Cite: | Sequence-Structure and Structure-Function Analysis in Cysteine-rich Domains Forming the Ultrastable Nematocyst Wall.
J.Mol.Biol., 368, 2007
|
|
1U0P
 | | Stable A-state hairpin of T4 fibritin foldon | | Descriptor: | fibritin | | Authors: | Meier, S, Guthe, S, Kiefhaber, T, Grzesiek, S. | | Deposit date: | 2004-07-14 | | Release date: | 2005-02-22 | | Last modified: | 2024-05-22 | | Method: | SOLUTION NMR | | Cite: | Foldon, the natural trimerization domain of T4 fibritin, dissociates into a monomeric A-state form containing a stable beta-hairpin: atomic details of trimer dissociation and
local beta-hairpin stability from residual dipolar couplings
J.Mol.Biol., 344, 2004
|
|
2HM6
 | | Nematocyst outer wall antigen, NW1 G11V K21P | | Descriptor: | Nematocyst outer wall antigen | | Authors: | Meier, S, Jensen, P.R, Grzesiek, S, Oezbek, S. | | Deposit date: | 2006-07-11 | | Release date: | 2007-02-06 | | Last modified: | 2021-10-20 | | Method: | SOLUTION NMR | | Cite: | Continuous molecular evolution of protein-domain structures by single amino Acid changes.
Curr.Biol., 17, 2007
|
|
2HM4
 | | Nematocyst Outer Wall Antigen, NW1 K21P | | Descriptor: | Nematocyst outer wall antigen | | Authors: | Meier, S, Jensen, P.R, Grzesiek, S, Oezbek, S. | | Deposit date: | 2006-07-11 | | Release date: | 2007-02-06 | | Last modified: | 2021-10-20 | | Method: | SOLUTION NMR | | Cite: | Continuous molecular evolution of protein-domain structures by single amino Acid changes.
Curr.Biol., 17, 2007
|
|
2HM5
 | | NW1, K21P, Structural Species II | | Descriptor: | Nematocyst outer wall antigen | | Authors: | Meier, S, Jensen, P.R, Grzesiek, S, Oezbek, S. | | Deposit date: | 2006-07-11 | | Release date: | 2007-02-06 | | Last modified: | 2021-10-20 | | Method: | SOLUTION NMR | | Cite: | Continuous molecular evolution of protein-domain structures by single amino Acid changes.
Curr.Biol., 17, 2007
|
|
2NX6
 | | Structure of NOWA cysteine rich domain 6 | | Descriptor: | Nematocyst outer wall antigen | | Authors: | Meier, S, Jensen, P.R, Adamczyk, P, Bachinger, H.P, Holstein, T.W, Engel, J, Ozbek, S, Grzesiek, S. | | Deposit date: | 2006-11-17 | | Release date: | 2007-10-02 | | Last modified: | 2023-12-27 | | Method: | SOLUTION NMR | | Cite: | Sequence-structure and structure-function analysis in cysteine-rich domains forming the ultrastable nematocyst wall.
J.Mol.Biol., 368, 2007
|
|
2NX7
 | | Structure of NOWA cysteine rich domain 8 | | Descriptor: | Nematocyst outer wall antigen | | Authors: | Meier, S, Jensen, P.R, Adamczyk, P, Bachinger, H.P, Holstein, T.W, Engel, J, Ozbek, S, Grzesiek, S. | | Deposit date: | 2006-11-17 | | Release date: | 2007-10-02 | | Last modified: | 2023-12-27 | | Method: | SOLUTION NMR | | Cite: | Sequence-structure and structure-function analysis in cysteine-rich domains forming the ultrastable nematocyst wall.
J.Mol.Biol., 368, 2007
|
|
8BWF
 | | PTBP1 RRM1 bound to an allosteric inhibitor | | Descriptor: | AMINO GROUP, GLYCEROL, Ligand, ... | | Authors: | Schmeing, S, Vetter, I, t Hart, P, Gasper, R. | | Deposit date: | 2022-12-06 | | Release date: | 2023-10-11 | | Last modified: | 2023-11-15 | | Method: | X-RAY DIFFRACTION (2.9 Å) | | Cite: | Rationally designed stapled peptides allosterically inhibit PTBP1-RNA-binding.
Chem Sci, 14, 2023
|
|
8ORB
 | |
5I9Y
 | | Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with dasatinib | | Descriptor: | 1,2-ETHANEDIOL, Ephrin type-A receptor 2, N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE | | Authors: | Kudlinzki, D, Linhard, V.L, Gande, S.L, Sreeramulu, S, Saxena, K, Heinzlmeir, S, Medard, G, Kuester, B, Schwalbe, H. | | Deposit date: | 2016-02-21 | | Release date: | 2016-11-09 | | Last modified: | 2024-01-10 | | Method: | X-RAY DIFFRACTION (1.228 Å) | | Cite: | Chemical Proteomics and Structural Biology Define EPHA2 Inhibition by Clinical Kinase Drugs.
ACS Chem. Biol., 11, 2016
|
|
5IA4
 | | Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with foretinib (XL880) | | Descriptor: | 1,2-ETHANEDIOL, Ephrin type-A receptor 2, N-(3-fluoro-4-{[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide | | Authors: | Kudlinzki, D, Linhard, V.L, Gande, S.L, Sreeramulu, S, Saxena, K, Heinzlmeir, S, Medard, G, Kuester, B, Schwalbe, H. | | Deposit date: | 2016-02-21 | | Release date: | 2016-11-09 | | Last modified: | 2024-01-10 | | Method: | X-RAY DIFFRACTION (1.797 Å) | | Cite: | Chemical Proteomics and Structural Biology Define EPHA2 Inhibition by Clinical Kinase Drugs.
ACS Chem. Biol., 11, 2016
|
|
5I9U
 | | Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase | | Descriptor: | 1,2-ETHANEDIOL, Ephrin type-A receptor 2 | | Authors: | Kudlinzki, D, Linhard, V.L, Gande, S.L, Sreeramulu, S, Saxena, K, Heinzlmeir, S, Medard, G, Kuester, B, Schwalbe, H. | | Deposit date: | 2016-02-21 | | Release date: | 2016-11-09 | | Last modified: | 2024-01-10 | | Method: | X-RAY DIFFRACTION (1.889 Å) | | Cite: | Chemical Proteomics and Structural Biology Define EPHA2 Inhibition by Clinical Kinase Drugs.
ACS Chem. Biol., 11, 2016
|
|
5IA1
 | | Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with MLN8054 | | Descriptor: | 1,2-ETHANEDIOL, 4-{[9-CHLORO-7-(2,6-DIFLUOROPHENYL)-5H-PYRIMIDO[5,4-D][2]BENZAZEPIN-2-YL]AMINO}BENZOIC ACID, Ephrin type-A receptor 2 | | Authors: | Kudlinzki, D, Linhard, V.L, Gande, S.L, Sreeramulu, S, Saxena, K, Heinzlmeir, S, Medard, G, Kuester, B, Schwalbe, H. | | Deposit date: | 2016-02-21 | | Release date: | 2016-11-09 | | Last modified: | 2024-01-10 | | Method: | X-RAY DIFFRACTION (2.036 Å) | | Cite: | Chemical Proteomics and Structural Biology Define EPHA2 Inhibition by Clinical Kinase Drugs.
ACS Chem. Biol., 11, 2016
|
|
5I9V
 | | Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with AGS | | Descriptor: | Ephrin type-A receptor 2, PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER | | Authors: | Kudlinzki, D, Linhard, V.L, Gande, S.L, Sreeramulu, S, Saxena, K, Heinzlmeir, S, Medard, G, Kuester, B, Schwalbe, H. | | Deposit date: | 2016-02-21 | | Release date: | 2016-11-09 | | Last modified: | 2024-01-10 | | Method: | X-RAY DIFFRACTION (1.458 Å) | | Cite: | Chemical Proteomics and Structural Biology Define EPHA2 Inhibition by Clinical Kinase Drugs.
ACS Chem. Biol., 11, 2016
|
|
5IA3
 | | Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with PD173955 | | Descriptor: | 6-(2,6-DICHLORO-PHENYL)-8-METHYL-2-(3-METHYLSULFANYL-PHENYLAMINO)-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE, Ephrin type-A receptor 2 | | Authors: | Kudlinzki, D, Linhard, V.L, Gande, S.L, Sreeramulu, S, Saxena, K, Heinzlmeir, S, Medard, G, Kuester, B, Schwalbe, H. | | Deposit date: | 2016-02-21 | | Release date: | 2016-11-09 | | Last modified: | 2024-01-10 | | Method: | X-RAY DIFFRACTION (1.788 Å) | | Cite: | Chemical Proteomics and Structural Biology Define EPHA2 Inhibition by Clinical Kinase Drugs.
ACS Chem. Biol., 11, 2016
|
|
5I9W
 | | Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with ANP | | Descriptor: | 1,2-ETHANEDIOL, Ephrin type-A receptor 2, PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | | Authors: | Kudlinzki, D, Linhard, V.L, Gande, S.L, Sreeramulu, S, Saxena, K, Heinzlmeir, S, Medard, G, Kuester, B, Schwalbe, H. | | Deposit date: | 2016-02-21 | | Release date: | 2016-11-09 | | Last modified: | 2024-01-10 | | Method: | X-RAY DIFFRACTION (1.359 Å) | | Cite: | Chemical Proteomics and Structural Biology Define EPHA2 Inhibition by Clinical Kinase Drugs.
ACS Chem. Biol., 11, 2016
|
|
5IA5
 | | Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with golvatinib (E7050) | | Descriptor: | 1,2-ETHANEDIOL, Ephrin type-A receptor 2, golvatinib | | Authors: | Kudlinzki, D, Linhard, V.L, Gande, S.L, Sreeramulu, S, Saxena, K, Heinzlmeir, S, Medard, G, Kuester, B, Schwalbe, H. | | Deposit date: | 2016-02-21 | | Release date: | 2016-11-09 | | Last modified: | 2024-01-10 | | Method: | X-RAY DIFFRACTION (1.776 Å) | | Cite: | Chemical Proteomics and Structural Biology Define EPHA2 Inhibition by Clinical Kinase Drugs.
ACS Chem. Biol., 11, 2016
|
|
